Agenus (AGEN) Share-based Compensation (2010 - 2026)
Agenus (AGEN) posted quarterly Share-based Compensation of $2.0 million for Q1 2026, down 39.99% year-over-year from $3.3 million in Q1 2025, and up 26.02% quarter-over-quarter from $1.6 million in Q4 2025.
Agenus (AGEN) Share-based Compensation (2010 - 2026) Analysis & Trends
Agenus' Share-based Compensation history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation fell 39.99% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (down 92.44% YoY), while the FY2025 annual figure was $11.9 million, down 56.47% from the prior year.
- Share-based Compensation for Q1 2026 stood at $2.0 million, up from $1.6 million in the prior quarter.
- The five-year high for Share-based Compensation was $9.3 million in Q2 2024, with the low at $1.6 million in Q4 2025.
- The 5-year median for Share-based Compensation is $4.8 million (2025), against an average of $5.2 million.
- The sharpest annual moves came in 2022 and 2025: Share-based Compensation soared 347.22% in 2022, then slumped 65.2% in 2025.
- Agenus' Share-based Compensation stood at $9.2 million in 2022, then tumbled by 40.57% to $5.5 million in 2023, then decreased by 16.48% to $4.6 million in 2024, then plunged by 65.2% to $1.6 million in 2025, then advanced by 26.02% to $2.0 million in 2026.
- Business Quant data shows AGEN's Share-based Compensation at $2.0 million in Q1 2026, $1.6 million in Q4 2025, and $4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | 3.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.26 Mn |
| Jun 30, 2026 | 3.26 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Mar 31, 2026 | 2.00 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.44 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Sep 30, 2024 | 9.28 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Mar 31, 2024 | 4.20 Mn |